Meet America’s Most Patented “Useless” Substance: The Government’s Staggering Hypocrisy on Cannabis

The medical cannabis advocacy community is standing on the brink a new era, loaded with more unknowns than it has faced in literally decades. Which makes this moment, as much as any, an appropriate moment to examine laughably self-contradictory government pronouncements and actions related to medical use of marijuana.

The Utah Association for Responsible Cannabis Legislation

Press Release: The Utah Association for Responsible Cannabis Legislation to Host Summit: ‘Medical Cannabis: The Science. The Truth.’ in Salt Lake City

Utah Representative Gage Froerer, United Patients Group, and Sacred Roots of Healing bring professionals together for an evening of information, education and awareness on the science of cannabinoid medicine, the national political climate and the potential benefits to the people of Utah

Blocking Cannabis Decriminalization

The Hypocrisy Continues – Who’s Really Behind Blocking Cannabis Decriminalization and Why?

With the recent decision by the DEA to expand the number of marijuana growers in the US, while keeping it classified as a Schedule I drug, it seems as if the legalization movement is constantly taking one step forward, only to take one step back again. Dr. Sanjay Gupta, Medical Correspondent for CNN and creator of the documentary “Weed,” has called the gesture “symbolic” meaning that while the number of growers and opportunities for research have technically expanded

Marijuana Schedule 1

Reeking of Hypocrisy: What the DEA’s Decision to Keep Marijuana Schedule 1 Really Means

Last week, the United States Drug Enforcement Agency (DEA) decided to maintain marijuana’s status as a Schedule 1 Drug under the Controlled Substance Act. By definition, substances on Schedule 1 have been determined by the U.S. Food and Drug Administration (FDA) as having “no medical use whatsoever” and are also deemed to have a “high potential for abuse.” At the same time, the DEA’s decision came with a relaxation of some of the rules regarding medical cannabis research